Publications by authors named "B H Bay"

Background: Limited data exist on the impact of polyvascular disease (PolyVD) on clinical outcomes in female patients undergoing transcatheter aortic valve replacement (TAVR). We therefore sought to investigate clinical outcomes in women with versus without PolyVD undergoing TAVR.

Methods: Female participants from the multicentre Women's International Transcatheter Aortic Valve Implantation (WIN-TAVI) registry were categorized based on the presence or absence of PolyVD.

View Article and Find Full Text PDF

Aim: Due to the absence of validated bleeding risk tools in cancer patients undergoing percutaneous coronary intervention (PCI), we aimed to validate an adapted version of the Academic Research Consortium (ARC) High Bleeding Risk (HBR) criteria.

Methods: Consecutive patients with active or remission cancer undergoing PCI between 2012 and 2022 at Mount Sinai Hospital (New York, USA) were included. Patients were considered at HBR if they met at least one of the major ARC-HBR criteria, other than cancer, or two minor criteria.

View Article and Find Full Text PDF

Aims: We aimed to investigate the association between the burden of modifiable lifestyle risk factors (modLRF) with high-sensitivity cardiac troponins T and I (hsTnT/I) and clinical outcomes in a contemporary cohort.

Methods: Patients undergoing coronary angiography with available hsTnT/I concentrations and information about modLRF were included in the current single-centre study. The modLRF investigated were overweight, lack of physical activity, poor adherence to a Mediterranean diet and current smoking.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of baseline left ventricular ejection fraction (LVEF) on outcomes for women undergoing transcatheter aortic valve implantation (TAVI).
  • Among the 944 patients analyzed, most had preserved LVEF, but those with reduced LVEF experienced a higher incidence of safety issues at 1-year, including all-cause mortality and major vascular complications.
  • Overall, while reduced LVEF did not significantly affect efficacy outcomes, it was linked to a worse safety profile compared to those with preserved or mildly reduced LVEF.
View Article and Find Full Text PDF